Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

Blood

Volumn 97, Issue 10, 2001, Pages 3171-3176

  Auffermann Gretzinger, Susanne ^a   Keeffe, Emmet B ^a   Levy, Shoshana ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL SURFACE MARKER;

ADULT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CARCINOGENESIS; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL;

EID: 0035874506     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.3171     Document Type: Article

References (32)

1. Bell D, Young JW, Banchereau J. Dendritic cells. Adv Immunol. 1999;72:255-324.
2. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products [see comments]. J Exp Med. 1995;182:389-400.
3. Koch F, Stanzl U, Jennewein P, et al. High level IL-12 production by murine dendritic cells: up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10 [published erratum appears in J Exp Med. 1996 Oct 1;184: following 1590]. J Exp Med. 1996;184:741-746.
4. Kruse M, Rosorius O, Kratzer F, et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol. 2000;74:7127-7136.
5. Fugier-Vivier I, Servet-Delprat C, Rivailler P, et al. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med. 1997;186:813-823.
6. Kanto T, Hayashi N, Takehara T, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999;162:5584-5591.
7. Kakumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection [in process citation]. J Gastroenterol Hepatol. 2000;15:431-436.
8. Liang TJ, Seeff L, Hoofnagle JH. Pathogenesis, natural history, treatment and prevention of hepatits C. Ann Intern Med. 2000;132:296-305.
9. + T cells with viral clearance in acute hepatitis C. J Infect Dis. 2000;181:1528-1536.
10. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000;191:1499-1512.
11. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000;6:578-582.
12. Tsai SL, Uaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology. 1997;25:449-458.
13. + T lymphocytes in acute and chronic hepatitis C. J Mol Med. 1996;74:583-588.
14. Cramp ME, Carucci P, Rossol S, et al. Hepatitis C virus (HCV)-specific immune responses in anti-HCV-positive patients without hepatitis C viraemia. Gut. 1999;44:424-429.
15. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109-1118.
16. Nijman HW, Kleijmeer MJ, Ossevoort MA, et al. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J Exp Med. 1995;182:163-174.
17. Kitajima T, Caceres-Dittmar G, Tapia FJ, et al. T cell-mediated terminal maturation of dendritic cells: loss of adhesive and phagocytotic capacities. J Immunol. 1996;157:2340-2347.
18. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States: the sentinel counties chronic non-A, non-B hepatitis study team [see comments]. N Engl J Med. 1992;327:1899-1905.
19. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C [see comments]. Ann Intern Med. 1996;125:658-668.
20. Seeff LB. Natural history of hepatitis C. Am J Med. 1999;107:10S-15S.
21. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol. 1997;71:6011-6019.
22. Cooper S, Erickson AL, Adams EJ, et al. Analysis of a successful immune response against hepatitis C virus. Immunity. 1999;10:439-449.
23. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
24. Timmerman JM, Levy R. Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med. 1999;50:507-529.
25. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells [see comments]. Nat Med. 1998;4:328-332.
26. Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids [see comments]. Nat Med. 2000;6:332-336.
27. Labeur MS, Roters B, Pers B, et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dehdritic cell maturation stage. J Immunol. 1999;162:168-175.
28. Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994;180:1263-1272.
29. Shreedhar V, Moodycliffe AM, Ullrich SE, et al. Dendritic cells require T cells for functional maturation in vivo. Immunity. 1999;11:625-636.
30. + T-helper and a T-killer cell [see comments]. Nature. 1998;393:474-478.
31. Vendetti S, Chai JG, Dyson J, et al. Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol. 2000;165:1175-1181.
32. He XS, Rehermann B, Lopez-Labrador FX, et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A. 1999;96:5692-5697.